• Title/Summary/Keyword: Osteoimmunology

Search Result 4, Processing Time 0.018 seconds

Osteoimmunology: A Brief Introduction

  • Greenblatt, Matthew B.;Shim, Jae-Hyuck
    • IMMUNE NETWORK
    • /
    • v.13 no.4
    • /
    • pp.111-115
    • /
    • 2013
  • Recent investigations have demonstrated extensive reciprocal interactions between the immune and skeletal systems, resulting in the establishment of osteoimmunology as a cross-disciplinary field. Here we highlight core concepts and recent advances in this emerging area of study.

Osteoimmunology: cytokines and the skeletal system

  • Lee, Seoung-Hoon;Kim, Tae-Soo;Choi, Yong-Won;Lorenzo, Joseph
    • BMB Reports
    • /
    • v.41 no.7
    • /
    • pp.495-510
    • /
    • 2008
  • It has become clear that complex interactions underlie the relationship between the skeletal and immune systems. This is particularly true for the development of immune cells in the bone marrow as well as the functions of bone cells in skeletal homeostasis and pathologies. Because these two disciplines developed independently, investigators with an interest in either often do not fully appreciate the influence of the other system on the functions of the tissue that they are studying. With these issues in mind, this review will focus on several key areas that are mediated by crosstalk between the bone and immune systems. A more complete appreciation of the interactions between immune and bone cells should lead to better therapeutic strategies for diseases that affect either or both systems.

Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis

  • Youn-Kwan Jung;Young-Mo Kang;Seungwoo Han
    • IMMUNE NETWORK
    • /
    • v.19 no.1
    • /
    • pp.2.1-2.13
    • /
    • 2019
  • The enhanced differentiation and activation of osteoclasts (OCs) in the inflammatory arthritis such as rheumatoid arthritis (RA) and gout causes not only local bone erosion, but also systemic osteoporosis, leading to functional disabilities and morbidity. The induction and amplification of NFATc1, a master regulator of OC differentiation, is mainly regulated by receptor activator of NF-κB (RANK) ligand-RANK and calcium signaling which are amplified in the inflammatory milieu, as well as by inflammatory cytokines such as TNFα, IL-1β and IL-6. Moreover, the predominance of CD4+ T cell subsets, which varies depending on the condition of inflammatory diseases, can determine the fate of OC differentiation. Anti-citrullinated peptide antibodies which are critical in the pathogenesis of RA can bind to the citrullinated vimentin on the surface of OC precursors, and in turn promote OC differentiation and function via IL-8. In addition to adaptive immunity, the activation of innate immune system including the nucleotide oligomerization domain leucine rich repeat with a pyrin domain 3 inflammasome and TLRs can regulate OC maturation. The emerging perspectives about the diverse and close interactions between the immune cells and OCs in inflammatory milieu can have a significant impact on the future direction of drug development.